2 studies found for:    16525139 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Busulfan and Melphalan Conditioning in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: BUSULFEX®;   Drug: Alkeran®
2 Active, not recruiting TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: Ara-C;   Drug: BCNU;   Drug: Cisplatin;   Drug: Cytoxan;   Drug: Dexamethasone;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Filgrastim;   Drug: Recombinant GM-CSF;   Drug: Interferon-alpha-2b;   Drug: Melphalan;   Drug: Vincristine

Indicates status has not been verified in more than two years